MedTrace Logo

Dexamethasone Intravitreal Implant in Retinal Vein Occlusion

NCT03559491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-06-18

No results posted yet for this study

Summary

Purpose: To evaluate retinal functional improvement by means of visual acuity and retinal sensibility examination after intravitreal dexamethasone implant in patients affected by cystoid macular edema secondary to retinal vein occlusion.

Conditions

  • Macular Edema, Cystoid

Interventions

DRUG

Intravitreal injection

Long term release steroid injection

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    lead OTHER

Principal Investigators

  • Simone Donati, MD · Università dell'Insubria

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-10-01
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03559491 on ClinicalTrials.gov